Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05285605 · ClinicalTrials.gov registry record
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 75
- Enrollment target
NCT05285605 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 75 participants.
The verdict
NCT05285605 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contraception and study the use of EC overall as well as with regards to participants' perception of reproductive autonomy. The investigators hypothesize that providing an advance supply of EC will increase use and decrease barriers to use. Additionally, the investigators hypothesize that, with thorough EC counseling, participants will develop an increased knowledge base of EC. With increased use and knowledge, the investigators hypothesize that participants will experience greater reproductive autonomy over their contraceptive decisions.
Interventions
- DRUG Ulipristal Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2024-01-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05285605
The ClinicalTrials.gov registry entry for NCT05285605 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulipristal Acetate is the first listed.
NCT05285605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05285605 about?
NCT05285605 is a clinical study titled "Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy". This study will entail provision of ulipristal acetate (UPA) for emergency contraception (EC) in the postpartum period for patients who have not chosen to initiate a highly effective form of contraception and study the use of EC overall as well as with regards to participants' perception of reproduc...
What is the current status of trial NCT05285605?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2022-03-01. Estimated completion is 2024-01-22.
What interventions are being tested in trial NCT05285605?
The interventions under investigation include: Ulipristal Acetate (DRUG).
Who is sponsoring clinical trial NCT05285605?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.